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From June 2014 through February 2015, respiratory 
samples from 130 Danish patients were screened for 
enterovirus D68 (EV-D68). Fourteen EV-D68 cases 
were detected, of which 12 presented with respira-
tory symptoms, and eight had known underlying dis-
ease. The median age of EV-D68 cases was three years 
(interquartile range: 0–30 years). Acute flaccid paraly-
sis (AFP) was not detected although Danish EV-D68 
strains showed > 98% nt identity with EV-D68-strains 
from AFP cases from the United States and France.
This study reports the burden and characteristics of 
enterovirus D68 (EV-D68) disease in Denmark from 
June 2014 through February 2015. A retro- and prospec-
tive EV-D68 surveillance study was implemented at 
the National Danish World Health Organization (WHO) 
Reference Laboratory for Poliovirus at Statens Serum 
Institut (SSI) Copenhagen, in September 2014 as a 
result of the extensive outbreak of severe respiratory 
disease caused by EV-D68 in the United States (US) [1] 
and Canada [2] that started in July 2014. Surveillance 
for EV-D68 in respiratory samples has continued in 
Denmark since then. A number of neurological cases 
associated with EV-D68 have also been reported [3-5], 
as well as a small number of likely EV-D68 associated 
fatalities [6].
Laboratory investigation 
In the study, we included a total of 1,322 samples, pre-
dominantly of respiratory origin, but also cerebrospinal 
fluid and unspecified swabs from patients from gen-
eral practitioners (GPs) (26%) and hospital inpatients 
(74%). Samples were submitted to SSI for diagnostic 
testing for respiratory viruses, and respiratory sam-
ples of both GP (2%) and hospital origin (98%) were 
submitted for EV genotyping as part of the national EV 
surveillance [7], between 1 June 2014 and 28 February 
2015. Informed consent from patients was not required 
according to Danish legislation regarding use of sam-
ples collected for surveillance purposes. Human rhino-
virus (HRV) ribonucleic acid (RNA) was detected using 
an in-house real-time RT (reverse transcriptase)-PCR 
assay, and EV RNA was detected using primers 
described previously [8], both assays targeting the 
5’non-translated region (NTR) and expected to detect 
all HRV and EV genotypes. A total of 130 samples rep-
resenting 119 individuals tested positive for either 
HRV, EV, or HRV and EV. Of the 130 samples, 61 (47%) 
were EV-positive only, 41 (31.5%) were HRV positive 
only, and 28 (21.5%) were both EV and HRV positive 
(Table 1). Nasopharyngeal secretion was the most com-
monly submitted sample material, followed by tracheal 
secretion.
Ninety-two samples were from children (range 0–15 
years of age) and 38 samples were from adults (range 
21–88 years of age). The sex distribution was slightly 
Table 1
Clinical samples screened for enterovirus D68, Denmark, 
1 June 2014 to 28 February 2015 (n=130)
Sample material
Diagnostic finding
Total
EV EV and HRV HRV
BAL 1 0 5 6
Biopsya 4 0 0 4
CSF 2 0 0 2
Expectorate 2 2 0 4
Nasopharyngeal secretion 28 13 11 52
Swabb 1 4 3 8
Tracheal secretion 17 5 10 32
Unspecified 6 4 12 22
Total 61 28 41 130
BAL: bronchoalveolar lavage; CSF: cerebrospinal fluid; EV: 
enterovirus; HRV: human rhinovirus.
a  Biopsy materials included lung and lymph node tissue.
b Swabs were taken from unspecified locations and tongue.
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skewed as 51/92 of children were male and 22/38 
adults were female.
All samples that tested positive for EV and/or HRV RNA 
in the diagnostic test were screened with an EV-D68 
specific real-time RT-PCR [9]. As part of the Danish 
enterovirus surveillance system all EV positive sam-
ples were further characterised at the National WHO 
Reference Laboratory for Poliovirus at SSI, using the 
routine genotyping assay which amplifies part of the 
VP2 or VP1 region [10,11] followed by Sanger sequenc-
ing [7]. Fourteen patients were identified as EV-D68-
positive (Table 2).
Twelve of these cases were detected using the EV-
D68 specific real-time RT-PCR, two were detected by 
sequencing the amplicon from the VP2 PCR (data not 
shown). Eight were EV- and HRV-positive in the initial 
diagnostic test, the remaining six were EV-positive. All 
EV-D68 cases were detected between September and 
November 2014, which corresponds to the main peak 
of the EV season in Denmark 2014 (Figure 1, Table 2). 
Information on duration of illness was available for 10 
patients, and patients with underlying conditions had 
a longer duration of illness (three weeks or longer, 
Table 2
Enterovirus D68-positive cases Denmark, detected between September and November 2014 (n=14)
Case Clinical information Underlying disease Age Sampling date Sample material Diagnostic findings
1
Pneumonia and 
respiratory failure lasting 
four weeks
Pulmonary defect and asthma 2 24 Sep 2014 Tracheal secretion EV  and HRV-positive
2
Acute bronchitis, repeated 
admissions during a three-
month period
Pulmonary defect and/or 
chronic lung disease 0 30 Sep 2014 Tracheal secretion
EV- and  HRV- 
positive
3 Cough and fever Malignancy 1 9 Oct 2014 Nasopharyngeal secretion EV-positive
4 Pneumonia Pulmonary defect and/or chronic lung disease 7 13 Oct 2014
Nasopharyngeal 
secretion EV-positive
5 Acute respiratory failure Cardiac disease and/or chronic lung disease 4 14 Oct 2014
Nasopharyngeal 
secretion
EV- and HRV 
positive
6 Coughing and fever lasting three weeks
Cardiac disease and/or chronic 
lung disease 0 20 Oct 2014
Nasopharyngeal 
secretion EV-positive
7
Asthmatic wheezing 
for seven days, not 
responding to standard 
inhalation treatment
None 2 24 Oct 2014 Nasopharyngeal secretion EV-positive
8 Low grade
a fever for four 
days None 3 27 Oct 2014
Nasopharyngeal 
secretion
EV- and HRV- 
positive
9
Acute onset, throat pain, 
coughing, muscle pain, 
fatigue, fever 38–39 °C, 
severe congestion and 
runny nose, lasting eight 
days
None 61 3 Nov 2014 Expectorate EV- and HRV-positive
10 Mild pharyngitis for five days None 30 4 Nov 2014 Unspecified
EV- and HRV-
positive
11 Cough and fever for one week None 0 26 Nov 2014 Tracheal secretion
EV- and 
HRV-positive
12
Cough and fever for two 
weeks; acute breathing 
difficulties resulting in 
CPAP treatment upon 
hospital admission (nine 
days).
None 68 26 Nov 2014 Unspecified EV- and  HRV-positive
13 Cough, congestion and fever lasting 21 days Malignancy 3 26 Nov 2014
Nasopharyngeal 
secretion EV-positive
14 Asthmatic cough and fever for four weeks Malignancy 5 27 Nov 2014
Nasopharyngeal 
secretion EV-positive
CPAP: continuous positive airway pressure; EV: enterovirus; HRV: human rhinovirus.
a  Fever <38°C.
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compared with four to 14 days for patients with no 
underlying condition).
All EV-D68-positive samples from 2014, as well as 
historical samples, were characterised using an assay 
specific for the VP1 region of EV-D68 [12] and included 
in the phylogenetic analysis.
All PCR amplicons were sequenced using the forward 
and reverse primers from the VP1 and VP2 assays on an 
ABI 3500 automated sequencer (Applied Biosystems). 
Sequences were assembled in BioNumerics v6.6 
(Applied Maths BV) and genotyped using BLAST anal-
ysis in the genotyping database and on GenBank. 
Sequences were aligned with published EV-D68 
sequences downloaded from GenBank using the SSE 
v1.1 software [13]. The most appropriate phylogenetic 
model for the data was found using the model test 
function in MEGA6 [14], and phylogenetic analysis was 
carried out using maximum likelihood with the Kimura 
2 parameter algorithm, gamma distribution, invariable 
sites and 1,000 bootstrap replications, also in MEGA6. 
Sequences obtained in this study were submitted to 
GenBank, accession numbers KP729103-KP729109, 
and KR108018 - KR108026. All primers used in this 
study can be seen in Table 3.
Phylogenetic analyses
All but two samples amplified successfully in the 
EV-D68 specific VP1 assay, producing sequences of 
around 800 nt. The two samples which could not be 
characterised using VP1 were the same two that failed 
to amplify in the real-time assay, and were confirmed 
to be EV-D68 by VP2 sequence analysis. Four historical 
EV-D68-positive samples were successfully amplified 
in the EV-D68 specific VP1 assay. BLAST analysis of the 
Danish VP1 sequences revealed that  6/12 of the Danish 
EV-D68 strains showed > 98% homology in 100% of 
the sequence (between 716 and 839 nt in length) 
with the US 2014 outbreak strains, and 2/12 strains 
showed > 98% homology with a EV-D68 strain from 
an acute flaccid paralysis (AFP) case in France case 
(LN626610). The remaining four Danish 2014 strains 
shared > 98% homology with other French 2014 EV-D68 
strains. Phylogenetic analysis of the 12 EV-D68 VP1 
sequences identified eight clusters containing Danish 
strains of EV-D68 (Figure 2). Eleven of the Danish 
strains from 2014 cluster within clade B as described 
by Tokarz et al., 2012 [12], one clusters within clade A. 
Strains from 2008, 2010, and 2013 cluster within clade 
A.
Discussion
EV-D68 which is a member of the large picornaviri-
dae family of viruses, has primarily been associated 
with mild to severe respiratory infections [15,16]. 
Historically, EV-D68 was only sporadically detected 
worldwide during the usual EV seasonal epidemics, 
but since 2008 the EV-D68 has occasionally given 
rise to larger outbreaks globally [15,17], although no 
previous outbreak has seen neither the same scale 
nor severity as the North American EV-D68 outbreak 
in 2014 [1]. Shortly after the North American outbreak 
was announced in July, EV-D68 cases were detected in 
Europe, and the European Centre for Disease Prevention 
and Control (ECDC) issued a rapid risk assessment on 
26 September 2014 [18]. Denmark joined an initiative 
started by the European Society for Clinical Virology 
(ESCV) to investigate the prevalence of EV-D68 in the 
European region in a retro- and prospective study cov-
ering June through November 2014.
In Denmark, ca 10% of respiratory samples tested 
between June 2014 and February 2015 were positive for 
EV and/or HRV, and of these 11% were determined to 
be EV-D68 by a combination of 5´NTR, VP1 and VP2 PCR 
and sequencing. This is a comparable detection rate 
to that described in other countries during the same 
time period [19]. No EV-D68 was detected in samples 
that were HRV-positive only, suggesting that the EV 
and HRV diagnostic result for EV-D68 cases is due to 
cross-reaction in the HRV assay. However, only 29.6% 
of double positive EV and HRV cases were associated 
with EV-D68. Other respiratory EV may also cross-react 
in an HRV assay in the 5’NTR, and, as a consequence, 
diagnostic laboratory reports from SSI for samples 
which are EV and HRV positive now contain a comment 
stating that this result may be due to infection with a 
virus detectable using both assays, rather than a dou-
ble infection. The number of samples with this result 
has historically been small at SSI; should it continue to 
increase beyond the 10% rate identified in this study, 
the HRV assay may need to be revised. 
Not all EV-D68 samples were detected using real-time 
and VP1 PCR, illustrating the difficulties in detecting 
and genotyping EVs in general due to the high level of 
diversity within this family of viruses. Danish strains 
Figure 1
Seasonal distribution of cases of enterovirus and 
enterovirus D68 infection, Denmark, 2014
EV: enterovirus.
Samples taken between January and May 2014 were not screened 
for the presence of enterovirus D68.
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were genetically very closely related to strains from 
AFP cases in the US and France, and AFP cases have 
also been described in Norway [19,20]. Strains from 
2014 from countries other than Denmark also show a 
close genetic relationship to strains from AFP cases, 
suggesting host factors play an important role in the 
development of AFP as a result of EV-D68 infection. 
Underlying disease appears to increase the risk for 
severe infection, and therefore potentially also AFP. 
There is, however, no definite link between underly-
ing disease and development of AFP, suggesting the 
involvement of other host factors. The level of viraemia 
may also contribute.
Following the detection of the first Danish EV-D68 cases 
during the fall of 2014, the National WHO Reference 
Laboratory for Poliovirus at SSI communicated these 
findings, alongside a description of the EV-D68 epi-
demic in the US, to all Danish clinicians including gen-
eral practitioners and microbiologists with an appeal 
for vigilance regarding severe respiratory symptoms 
and AFP. Newsletters were posted on the National 
Clinical and Microbiology Societies websites and sent 
out using mailing lists, and an article was published in 
the weekly epidemiological Bulletin (EPI-NEWS) issued 
by the SSI [21]. Although Danish cases with EV-D68 
and underlying conditions did experience severe res-
piratory symptoms, no cases of AFP were reported.
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Table 3
Primers used for the detection and amplification of enterovirus D68
Assay Target region Forward primer
a Reverse primera Probe
EV diagnostic [8] 5' NTR GGTGCGAAGAGTCTATTGAGC CACCCAAAGTAGTCGGTTCC FAM-CCGGCCCCTGAATG-MGB
EV-D68 specific 
diagnostic 5'NTR TGTTCCCACGGTTGAAAACAA TGTCTAGCGTCTCATGGTTTTCAC
FAM-TCCGCTATAGTACTTCG-MGB
FAM-ACCGCTATAGTACTTCG-MGB
Nasri [10] VP2
GARGCITGYGGITAYAGYGA TTDATDATYTGRTGIGG
NA
GARGARTGYGGITAYAGYGA
TTDATCCAYTGRTGIGGGGITGGTGGTGGAARYTICC
GGITGGTAYTGGAARTTICC
Nix [11] VP1
GCIATGYTIGGIACICAYRT GTYTGCCA
NA
GAYTGCCA
CCAGCACTGACAGCAGYNGARAYNGG
CCRTCRTA
RCTYTGCCA
CICCIGGIGGIAYRWACAT
TACTGGACCACCTGGNGGNAYRWACAT
Tokarz [12] VP1
CCTTAATAGGGTTCATAGCAGC CTGGGCCGGTGGTYACTA
NA
ATGAGAGAYAGYCCTGACATTG CATTGAGBGCATTTGGTGCT
EV: enterovirus; NA: not applicable.
a  Degenerate bases: I- inosine, B- C/G/T, D- A/G/T, N- A/C/G/T, R- A/G, Y- C/T, W-A/T.
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Figure 2
Phylogenetic analysis of enterovirus D68 VP1 sequences
The phylogenetic tree was constructed by maximum likelihood, with the Kimura 2-parameter algorithm, with gamma distribution, invariable 
sites and 1,000 bootstrap replicates, using MEGA6. Only bootstrap values > 70% are indicated. Branch lengths are drawn to the indicated 
scale, proportion of nt substitutions per site. Sequences were 731 nt in length. Reference sequences were downloaded from GenBank; all 
complete or near complete genomes (n = 50, downloaded 14 Apr 2015), as well as partial VP1 sequences > 700 nt in length with complete 
overlap with the sequences from this study (n = 232, downloaded 14 Apr 2015) were included, resulting in a dataset of 294 sequences. 
GenBank reference sequences and sequences from this study are identified by their accession numbers. Country of origin and detection 
year is specified after the sequence ID (where available) for references and study samples within defined clusters. Four EV-D68 sequences 
from the Danish genotyping database, identified between 2008 and 2013, were also included in the analysis. Sequences from this study are 
identified with filled circles and bold text. Reference sequences from known acute flaccid paralysis cases are identified with bold italics.
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JF896287 NETHERLANDS 2010
100
98
87
93
74
70
93
90
100
96
98
0.002
LN681317 FRANCE 2014
LN681316 FRANCE 2014
LN681331 FRANCE 2014
KP729106 DENMARK 2014
KP153538 ITALY 2014
LN681328 FRANCE 2014
KR108021 DENMARK 2013
LN681336 FRANCE 2014
KM851231 USA 2014
JX898786 CHINA 2012
KF254914 SPAIN 2013
JX898784 CHINA 2010
KF726085 CHINA 2008
AB667899 JAPAN 2008
JX101802 SOUTH AFRICA 2000
AB667896 JAPAN 2006
AY426500 USA
96
73
71
100
100
95
0.005
6 www.eurosurveillance.org
References
1. Midgley CM, Jackson MA, Selvarangan R, Turabelidze G, 
Obringer E, Johnson D, et al. Severe respiratory illness 
associated with enterovirus D68 - Missouri and Illinois, 
2014. MMWR Morb Mortal Wkly Rep. 2014;63(36):798-9. 
PMID:25211545
2. National Collaborating Centre for Infectious Diseases (NCCID). 
Disease debrief: EV-D68. Winnipeg, Manitoba: NCCID. 
[Accessed 21 Nov 2014]. Available from: http://www.nccid.ca/
disease-debrief-ev-d68#Q1.
3. Pastula DM, Aliabadi N, Haynes AK, Messacar K, Schreiner T, 
Maloney J, et al.; Centers for Disease Control and Prevention 
(CDC). Acute neurologic illness of unknown etiology in children 
- Colorado, August-September 2014. MMWR Morb Mortal Wkly 
Rep. 2014;63(40):901-2. PMID:25299607
4. British Columbia Centre for Disease Control. Emerging 
respiratory virus bulletin: MERS-CoV, Influenza A(H7N9) 
and A(H3N2)v, Enterovirus D68. British Columbia: Centre 
for Disease Control. 4 Oct 2014. Available from: http://
www.bccdc.ca/NR/rdonlyres/88FD3DD4-BEB0-4F29-93C0-
6093A7AFBD4B/0/Full_ERVUpdate20141004.pdf
5. Lang M, Mirand A, Savy N, Henquell C, Maridet S, Perignon 
R, et al. Acute flaccid paralysis following enterovirus 
D68 associated pneumonia, France, 2014. Euro Surveill. 
2014;19(44):20952. http://dx.doi.org/10.2807/1560-7917.
ES2014.19.44.20952 PMID:25394254
6. Centers for Disease Control and Prevention. Non-Polio 
Enterovirus: Enterovirus D68. Atlanta: National Center for 
Immunization and Respiratory Diseases (NCIRD), Division of 
Viral Diseases, Centers for Disease Control and Prevention. 
Updated 23 Mar 2015. Available from: http://www.cdc.gov/
non-polio-enterovirus/about/ev-d68.html
7. Fischer TK, Nielsen AY, Sydenham TV, Andersen PH, Andersen 
B, Midgley SE. Emergence of enterovirus 71 C4a in Denmark, 
2009 to 2013. Euro Surveill. 2014;19(38):20911. http://dx.doi.
org/10.2807/1560-7917.ES2014.19.38.20911 PMID:25306878
8. Nielsen AC, Böttiger B, Midgley SE, Nielsen LP. A novel 
enterovirus and parechovirus multiplex one-step real-
time PCR-validation and clinical experience. J Virol 
Methods. 2013;193(2):359-63. http://dx.doi.org/10.1016/j.
jviromet.2013.06.038 PMID:23845901
9. Poelman R, Schölvinck EH, Borger R, Niesters HGM, van 
Leer-Buter C. The emergence of enterovirus D68 in a Dutch 
University Medical Center and the necessity for routinely 
screening for respiratory viruses. J Clin Virol. 2015;62:1-5. 
http://dx.doi.org/10.1016/j.jcv.2014.11.011 PMID:25542461
10. Nasri D, Bouslama L, Omar S, Saoudin H, Bourlet T, Aouni M, et 
al. Typing of human enterovirus by partial sequencing of VP2. 
J Clin Microbiol. 2007;45(8):2370-9. http://dx.doi.org/10.1128/
JCM.00093-07 PMID:17537940
11. Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR 
amplification of VP1 sequences for direct identification of all 
enterovirus serotypes from original clinical specimens. J Clin 
Microbiol. 2006;44(8):2698-704. http://dx.doi.org/10.1128/
JCM.00542-06 PMID:16891480
12. Tokarz R, Firth C, Madhi SA, Howie SR, Wu W, Sall AA, et al. 
Worldwide emergence of multiple clades of enterovirus 68. J 
Gen Virol. 2012;93(Pt 9):1952-8. http://dx.doi.org/10.1099/
vir.0.043935-0 PMID:22694903
13. Simmonds P. SSE: a nucleotide and amino acid sequence 
analysis platform. BMC Res Notes. 2012;5(1):50. http://dx.doi.
org/10.1186/1756-0500-5-50 PMID:22264264
14. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: 
Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol 
Evol. 2013;30(12):2725-9. http://dx.doi.org/10.1093/molbev/
mst197 PMID:24132122
15. Meijer A, van der Sanden S, Snijders BE, Jaramillo-Gutierrez 
G, Bont L, van der Ent CK, et al. Emergence and epidemic 
occurrence of enterovirus 68 respiratory infections in The 
Netherlands in 2010. Virology. 2012;423(1):49-57. http://
dx.doi.org/10.1016/j.virol.2011.11.021 PMID:22177700
16. Renois F, Bouin A, Andreoletti L. Enterovirus 68 in pediatric 
patients hospitalized for acute airway diseases. J Clin 
Microbiol. 2013;51(2):640-3. http://dx.doi.org/10.1128/
JCM.02640-12 PMID:23224095
17. Meijer A, Benschop KS, Donker GA, van der Avoort HG. 
Continued seasonal circulation of enterovirus D68 in the 
Netherlands, 2011-2014. Euro Surveill. 2014;19(42):20935. 
http://dx.doi.org/10.2807/1560-7917.ES2014.19.42.20935 
PMID:25358039
18. Eurosurveillance editorial team. ECDC’s latest publications. 
Euro Surveill. 2014;19(39):20915. Available from: http://www.
eurosurveillance.org/ViewArticle.aspx?ArticleId=20915
19. Bragstad K, Jakobsen K, Rojahn AE, Skram MK, Vainio K, 
Holberg-Petersen M, et al. High frequency of enterovirus D68 
in children hospitalised with respiratory illness in Norway, 
autumn 2014. Influenza Other Respi Viruses. 2015;9(2):59-63.
20. Pfeiffer HC, Bragstad K, Skram MK, Dahl H, Knudsen PK, 
Chawla MS, et al. Two cases of acute severe flaccid myelitis 
associated with enterovirus D68 infection in children, Norway, 
autumn 2014. Euro Surveill. 2015;20(10):21062. http://dx.doi.
org/10.2807/1560-7917.ES2015.20.10.21062 PMID:25788251
21. Fischer TK, Midgley SE, Poulsen MW, Andersen B, Christiansen 
CB, Andersen PH. Outbreak of enterovirus D68 in children 
in USA and Canada, and circulation in Denmark. EPI-NYT 
2014;49. Available from: http://www.ssi.dk/pdf.ashx?title=No-
49---2014---EPI-NEWS&url=http%3a%2f%2fwww.
ssi.dk%2fEnglish%2fNews%2fEPI-
NEWS%2f2014%2fNo+49+-+2014.aspx%3fpdf%3d1
